The Confederation s research policy and it s role in promoting clinical research

Transcription

1 The Confederation s research policy and it s role in promoting clinical research Forum «Klinische Forschung» Jürg Burri Staatssekretariat für Bildung, Forschung und Innovation SBFI Leiter Direktionsbereich Forschung und Innovation

2 Content I The Confederation s ERI-policy and the federal system for promoting research II Public promoting of clinical research III Conclusions 2

3 I. The Confederation s ERI policy ERI in a global context ERI system 3

4 Federal system for promoting research Bottom-up: investigator/science driven research activities Principle of competition Selection criteria based on excellence Autonomy of researchers and institutions Basic research performed in research universities Applied research performed by the private sector and in universities for applied sciences 4

5 Confederation s main financial means in million CHF / budget National research institutions and infrastructures SNSF Competitive funding for research and innovation: 900 Contributions for cantonal universities: 2350 ETH-Domain CTI 130 Horizon Cantonal universities

6 II. Public promoting of clinical research Investigator driven clinical research is supported by Projects Grants of Universities and Hospitals the Swiss National Science Foundation the European Framework Program for Research and Innovation Horizon2020 ( EDCTP; ECRIN) Infrastructure Cantonal level: (University-) Hospitals, Medical Faculties, direct contributions Direct federal contributions for national research institutions and infrastructures (art. 15 FIFG/LERI) 6

7 Swiss Group for Clinical Cancer Research Disease specific clinical trial organization Direct federal support for clinical research projects and infrastructure since 1992 National action plan to combat cancer: a priority of the national health policy 7

8 Swiss Clinical Trial Organisation SCTO and Clinical Trial Units CTUs (I) Mandate of SERI to the Swiss National Science Foundation to establish a disease unspecific Clinical Trial Organization SNSF: competitive call for Clinical Trial Units in 2007/2008 and initial support for up to five years SCTO a umbrella organization - coordinates the collaboration between the CTUs and builds bridges between academia, industry and public authorities 8

9 Swiss Clinical Trial Organisation SCTO and Clinical Trial Units (II) As from 2017 the SCTO and the CTUs will benefit as research infrastructures of national importance from direct federal contributions. In the long term: - one disease unspecific Swiss Centre for Clinical Trials as a hub and local Clinical Trial Units as satellites - well organized collaborative groups in the various fields of clinical research using the services offered by the Centre for Clinical Trials and the CTUs 9

10 Facts and figures Research Portfolio 30% Arts & Humanities Arts & Humanities 8% 2% Social & Social & Behavioral Behavioral Sciences Sciences 6% 1% 8% 2% Life Life Sciences sciences 32% 8% 30% 9% 9% Physical, Chemical & Physical, Earth Sciences Chemical & Earth Sciences 26% 26% Switzerland 26% 17% 20% Clinical Clinical Medicine Medicine 8% 7% 9% Engineering, Computing Engineering, Agriculture, & Technology Biology Agriculture, & Environmental Biology Sciences Computing & & Environmental Technology Sciences 17% World Quelle: Bibliometrische Untersuchung zur Forschung in der Schweiz , SBFI

11 III. Conclusions Investigator driven clinical research projects: Competitive calls Scientific excellence Budget for reimbursing «CRO»-services of a CTU Confederation co-funds infrastructures respectively «CRO»-services for academic clinical research projects Collaboration between academia and industry is a prerequisite for effective clinical research activities 11

12 Thank you for your attention! More information: 12